Paper39205170
Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection.
Smith A and 3 others. Viruses, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection. Papers, record 39205170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39205170
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ribonuclease P | Major topic |
| Cytomegalovirus | Major topic |
| RNA, Catalytic | Major topic |
| Cytomegalovirus Infections | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Virus Replication | |
| Genetic Engineering | |
| Antiviral Agents | |
| Genetic Therapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Start-Up Fund 101 | University of California at Berkeley | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21076397 | Structure of a bacterial ribonuclease P holoenzyme in complex with tRNA. | Nature | 2010 | https://conductscience.org/library/papers/21076397 | PubMed |
| 2 | 1697102 | External guide sequences for an RNA enzyme. | Science | 1990 | https://conductscience.org/library/papers/1697102 | PubMed |
| 3 | 38965378 | The 60-year evolution of lipid nanoparticles for nucleic acid delivery. | Nat Rev Drug Discov | 2024 | https://conductscience.org/library/papers/38965378 | PubMed |
| 4 | 10496224 | UV cross-link mapping of the substrate-binding site of an RNase P ribozyme to a target mRNA sequence. | RNA | 1999 | https://conductscience.org/library/papers/10496224 | PubMed |
| 5 | 22826233 | Effective inhibition of cytomegalovirus infection by external guide sequences in mice. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22826233 | PubMed |
| 6 | 11381134 | Inhibition of Escherichia coli viability by external guide sequences complementary to two essential genes. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11381134 | PubMed |
| 7 | 15184661 | Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15184661 | PubMed |
| 8 | 9814760 | Inhibition of viral gene expression by human ribonuclease P. | RNA | 1998 | https://conductscience.org/library/papers/9814760 | PubMed |
| 9 | 15655805 | Long-term survival and concomitant gene expression of ribozyme-transduced CD4+ T-lymphocytes in HIV-infected patients. | J Gene Med | 2005 | https://conductscience.org/library/papers/15655805 | PubMed |
| 10 | 10811889 | Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10811889 | PubMed |
| 11 | 6197186 | The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. | Cell | 1983 | https://conductscience.org/library/papers/6197186 | PubMed |
| 12 | 24932966 | Engineered RNase P ribozymes effectively inhibit human cytomegalovirus gene expression and replication. | Viruses | 2014 | https://conductscience.org/library/papers/24932966 | PubMed |
| 13 | 2107573 | Ribozymes as potential anti-HIV-1 therapeutic agents. | Science | 1990 | https://conductscience.org/library/papers/2107573 | PubMed |
| 14 | 1384177 | In vitro genetics. | Trends Biochem Sci | 1992 | https://conductscience.org/library/papers/1384177 | PubMed |
| 15 | 21949365 | Basic peptide-morpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21949365 | PubMed |
| 16 | 2839827 | Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/2839827 | PubMed |
| 17 | 23481322 | Inhibition of hepatitis B virus gene expression and replication by ribonuclease P. | Mol Ther | 2013 | https://conductscience.org/library/papers/23481322 | PubMed |
| 18 | 38888787 | RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/38888787 | PubMed |
| 19 | 14623981 | Functional profiling of a human cytomegalovirus genome. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14623981 | PubMed |
| 20 | 19158789 | The promises and pitfalls of RNA-interference-based therapeutics. | Nature | 2009 | https://conductscience.org/library/papers/19158789 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42175530 | Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV. | Int J Immunopathol Pharmacol | 2026 | https://conductscience.org/library/papers/42175530 | PubMed |
| 41011617 | Potential Applications of RNase P Ribozyme Against Hepatitis B Virus. | Molecules | 2025 | https://conductscience.org/library/papers/41011617 | PubMed |
| 39861869 | Perspective on the 65-Year Anniversary of the Discovery of Cytomegalovirus. | Viruses | 2025 | https://conductscience.org/library/papers/39861869 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39205170
GET https://conductscience.org/api/papers/v1/39205170/references?page=2